
PHARMAMEDDEVICE, THE WORLD'S FIRST inclusive forum for the converging medical device, pharmaceutical and biological industries, announces a blue- ribbon advisory board. The distinguished advisory board members include leading experts from Johnson & Johnson, Vyteris, Medtronic and the Medical Device Manufacturers Association (MDMA). As combination product developers, former members of the FDA, medical doctors, lawyers and regulatory affairs professionals, PharmaMedDecive's advisory board brings a depth of expertise that is unmatched in the industry
This advisory board is instrumental in guiding conference programming and event positioning to meet the multi-dimensional needs of companies involved in combination products.
"The diversity of our advisory board has helped round out our conference program, while attracting leading medical device and pharmaceutical companies as exhibitors, speakers, endorsers and attendees," says Christine Ford, Event Director for PharmaMedDevice.
Many leaders from business, regulatory and academia are scheduled to exhibit, visit or present at PharmaMedDevice, April 24-26 in New York City, co-located with INTERPHEX. "Our participants will also benefit from PharmaMedDevice's co-location with INTERPHEX, the world's largest and most comprehensive pharmaceutical conference and exhibition," states Ford.

Explore the January February 2007 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Stryker raises full-year guidance despite muted investor reaction
- Unlocking 3D vision: Basler AG launches Stereo ace camera series
- Lisa Anderson, supply chain & manufacturing expert, comments on the One Big Beautiful Act and its implications for US manufacturers
- Tooling and clamping solutions for optimum machining performance
- BGS US launches state-of-the-art E-Beam sterilization facility
- How suppliers can adapt to the shifting EV landscape
- AI will power the next generation of medical wearables
- CUI Crash Course from Smithers